Milan, February 24th 2015 – Korn Ferry, a Korn Ferry (NYSE:KFY) company specialising in high-impact talent acquisition solutions has partnered with leading Italian pharmaceuticalcompany, Zambon to support its expansions plans, which includes the strategic development into new therapeutic areas.
With more than 2,600 employees across 21 operating subsidiaries, products commercialized in 73 countries, Zambon is an industrial international family company, with 109 years of experience in fine-chemical and pharmaceuticals industries. Turnover is 563 million Euro (2013), 78% of which is made abroad and the Group is carrying on a development plan consolidating the international growth strategy.
The relationship with Korn Ferry in Germany started in early 2014 when Korn Ferry was appointed to recruit for a number of management positions for the organisation’s German set-up, located in Berlin, and as a result of its success, Korn Ferry was selected to recruit a field force team of 24 sales representatives for Zambon’s Northern and Southern sales regions in Germany. The recruitment project began in July 2014 with the aim to be completed in under four months due to the commercial launch of Safinamide, a molecule for the treatment of Parkinson’s disease. The Korn Ferry recruitment team was dedicated to sourcing, screening, interviewing and presenting external candidates whilst facilitating the online application process and the supply of relevant timely reporting. Thanks to a robust sourcing strategy, 30 assessment days were coordinated in eight locations, enabling the recruitment of 24 new hires within the timeframe allocated.
Giovanni Strapazzon, HR Director at Zambon commented: “By partnering with Korn Ferry we are able to continue to support our business strategy, bringing vital talent on board to bolster our workforce and strengthen the investment we are making in growing the company. Through best-in-class methodology and innovative multi-channel sourcing, we have already been able to source and onboard suitable candidates very quickly, regardless of this highly fragmented and competitive market.”
Melanie Eder, Project Manager at Korn Ferry added: “Our ability to deliver these projects successfully was facilitated by a strong partnership with Zambon, alongside great communication and constant knowledge-transfer. We pride ourselves on building long-term relationships with our clients and becoming a trusted partner to market leading companies such as Zambon. As such, we are delighted to be expanding our relationship with Zambon further, supporting its talent management strategy in other key operating markets.”
For media enquiries please contact:
Georgina Greenspan/Olivia Allen, Harvard PR
T: +44 (0)20 7861 2835
Zambon Company SpA
T: +39 02 66524414
M: +39 3459251416
About Korn Ferry
Korn Ferry is the global industry leader in high-impact recruitment solutions; offering fully customized, flexible services to help organizations meet their talent and recruitment needs.
Our clients turn to us for proven expertise, a global process and infrastructure, proprietary competency models, innovative sourcing and attraction strategies, and a unique approach to measure and optimize business impact.
As a Korn Ferry Company, Korn Ferry can meet a variety of workforce requirements; from RPO and project recruitment, to search and consulting, our solutions apply a truly world-class capability to deliver talent with impact, providing the experience and global reach to identify, attract and retain the people who drive business success. To learn more, visit www.Korn Ferry.com.
About Korn Ferry
At Korn Ferry, we design, build, attract and ignite talent. Since our inception, clients have trusted us to help recruit world-class leadership. Today, we are a single source for leadership and talent consulting services to empower businesses and leaders to reach their goals. Our solutions range from executive recruitment and leadership development programs, to enterprise learning, succession planning and recruitment process outsourcing (RPO). Visit http://www.kornferry.com for more information on Korn Ferry, and http://www.kornferryinstitute.com for thought leadership, intellectual property and research.
Zambon is a leading Italian pharmaceutical and fine-chemical multinational company that has earned a strong reputation over the years for high quality products and services. Zambon is well-established in 3 therapeutic areas: respiratory, pain and woman care, and is very strongly committed to its entry into the CNS space. Zambon SpA produces high quality products thanks to the management of the whole production chain which involves Zach (Zambon chemical), a privileged partner for API, custom synthesis and generic products. The Group is strongly working on the treatment of the chronic respiratory diseases as asthma and BPCO and on the CNS therapeutic area with Safinamide for the Parkinson treatment. Zambon is headquartered in Milan and was established in 1906 in Vicenza. Zambon is present in 21 countries with subsidiaries and more than 2,600 employees with manufacturing units in Italy, Switzerland, France, China and Brazil. Zambon products are commercialized in 73 countries. For details on Zambon please see: www.zambongroup.com